Impact of Different Dialysis Solutions on Solute and Water Transport

Rippe B. , Stelin G. Simulations of peritoneal solute transport during CAPD. Application of two-poreformalism. Kidney Int 1989; 35: 1234–44.

Rippe B. , Stelin G. , Haraldson B. Computer simulations of peritoneal fluid transport in CAPD. Kidney Int 1991; 40: 315–25.

Hirszel P. , Shea-Donohue T. , Chakrabarti E. , Montcalm E. , Maher J.F. The role of the capillary wall in restricting diffusion of macromolecules. Nephron 1988; 49: 58–61.

Nagel W. , Kushinsky W. Study of the permeability of isolated dogmesentery Eur J ClinInvest 1970; 1: 149–54.

Rasio E.A. Metabolic control of permeability in isolated mesentery. Am J Physiol 1974; 226: 962–8.

Flessner M.F. Peritoneal transport physiology: insights from basic research. J Am Soc Nephrol 1991; 2: 122–35.

Flessner M.F. Osmotic barrier of the parietal peritoneum. Am J Physiol 1994; 267: F861–70.

Verger C. , Luger A. , Moore H.L. , Nolph K.D. Acute changes in peritoneal morphology and transport properties with infectious peritonitis and mechanical injury. Kidney Int 1983; 23: 823–31.

Zemel D. , Krediet R.T. Cytokine patterns in the effluent of continuous ambulatory peritoneal dialysis: relationship to peritoneal permeability. Blood Purif 1996; 14: 198–216.

Miller F.N. , Nolph K.D. , Joshua I.G. The osmolality component of peritoneal dialysis solutions. In: Legrain M. , ed. Continuous ambulatory peritoneal dialysis. Amsterdam: Excerpta Medica, 1980; 12–7.

Granger D.N. , Ulrich M. , Perry M.A. , Kvietys P.R. Peritoneal dialysis solutions and feline splanchnic blood flow. Clin Exp Pharmacol Physiol 1984; 11: 473–82.

Kagan A. , Bar-Khayim Y. , Schafer Z. , Fainara M. Kinetics of peritoneal protein loss during CAPD: 1. Different characteristics for low and high molecular weight proteins. Kidney Int 1990; 37: 971–9.

Imholz A.L.T. , Koomen G.C.M. , Struijk D.G. , Arisz L. , Krediet R.T. The effect of dialysate osmolality on the transport of low molecular weight solutes and proteins during CAPD. Kidney Int 1993; 43: 1339–46.

Pappenheimer J.R. Passage of molecules through capillary walls. Physiol Rev 1953; 33: 387–423.

Grotte G. Passage of dextran molecules across the blood-lymph barrier. Acta Chir Scand 1956; 211: 1–84.

Deen W.M. , Bohrer M.P. , Brenner B.M. Macromolecule transport across glomerular capillaries. Application of pore theory. Kidney Int 1979; 16: 353–65.

Pannekeet M.M. , Mulder J.B. , Weening J.J. , Struijk D.G. , Zweers M.M. , Krediet R.T. Demonstration of aquaporinchip in peritoneal tissue of uremic and CAPD patients. Perit Dial Int 1996; 16(Suppl l): S54–7.

Ho-dac-Pannekeet M.M. , Krediet R.T. Water channels in the peritoneum. Perit Dial Int 1996; 16: 255–9.

Ho-dac-Pannekeet M.M. , Schouten N. , Langedijk M.J. Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int 1996; 50: 979–86.

Nolph K.D. , Twardowski Z.J. , Popovich R.P. , Rubin J. Equilibration of peritoneal dialysis solutions during long-dwell exchanges. J Lab Clin Med 1979; 93: 246–56.

Canaud B. , Liendo-Liendo C. , Claret G. , Mion H. , Mion C. Étude “in situ” de la cinetique de l'ultrafiltration en cours de dialyse péritonéale avec périodes de diffusion prolongées. Néphrology 1980; 1: 126–32.

Heimbürger O. , Waniewski J. , Werynski A. , Lindholm B. A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int 1992; 41: 1320–32.

Imholz A.L.T. , Koomen G.C.M. , Struijk D.G. , Arisz L. , Krediet R.T. Fluid and solute transport in CAPD patients using ultralow sodium dialysate. Kidney Int 1994; 46: 333–40.

Zemel D. , Krediet R.T. , Koomen G.C.M. , Struijk D.G. , Arisz L. Day-to-day variability of protein transport used as a method for analyzing peritoneal permeability in CAPD. Perit Dial Int 1991; 11: 217–23.

Krediet R.T. , Zemel D. , Struijk D.G. , Koomen G.C.M. , Arisz L. Individual characterization of the peritoneal restriction barrier to macromolecules. Adv Perit Dial 1991; 7: 15–20.

Nolph K.D. , Hano J.E. , Teschan P.E. Peritoneal sodium transport during hypertonic peritoneal dialysis. Ann Intern Med 1969; 70: 931–41.

Nakayama N. , Yokoyama K. , Kubo H. , Watanabe S. , Kawaguchi Y. , Sakai O. Effects of ultralow Na concentration dialysate (UL Na D) for overhydrated patients undergoing CAPD. Perit Dial Int 1992; (Suppl 1): S143.

Nakayama N. , Kawaguchi Y. , Kubo H. , Miara Y. , Sakai O. Clinical effects of low Na concentration dialysate (120 mg/L) for CAPD patients. Perit Dial Int 1993; (Suppl 1): S76.

Leypoldt J.K. , Charney D.I. , Cheung A.K. , Napresktek C.L. , Akin B.H. , Shockley T.R. Ultrafiltration and solute kinetics using low sodium dialysate. Kidney Int 1995; 48: 1959–66.

Krediet R.T. , Boeschoten E.W. , Struijk D.G. , Arisz L. Differences in the peritoneal transport of water, solutes and proteins between dialysis with two- and with three-litre exchanges. Nephrol Dial Transplant 1988; 2: 198–204.

Merchant M.R. , Hutchinson A.J. , Butler S.J. , Boulton H. , Hincliffe R. , Gokal R. Calcium, magnesium mass transfer and lactate balance study in CAPD patients with reduced calcium/magnesium and high lactate dialysis fluid Adv Perit Dial 1992; 8: 365–8.

Uribarri J. , Buguing J. , Ok M.S. Acid-base balance in chronic peritoneal dialysis patients. Kidney Int 1995; 47: 269–73.

Feriani M. Adequacy of acid base correction in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1994; 14(Suppl 3): S133–8.

Feriani M. , Ronco C. , La Greca G. Acid-base balance with different CAPD solutions. Perit Dial Int 1996; 16(Suppl 1): S126–9.

Liberek T. , Topley N. , Jorres A. Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Nephron 1993; 65: 260–5.

Douvdevani A. , Rapoport J. , Konforty A. , Yulzari R. , Moran A. , Chaimovitz C. Intracellular acidification mediates the inhibitory effect of peritoneal dialysate on peritoneal macrophages. J Am Soc Nephrol 1995; 6: 207–13.

Ing TS , Quon M.G. , Daugirdas J.T. On line preparation of bicarbonate containing dialysate for PD. Int J Artif Organs 1983; 4: 308–11.

Feriani M. , Dissegna D. , La Greca G. , Passlick-Deetjen J. Short-term clinical study with bicarbonate-containing peritoneal dialysis solution. Perit Dial Int 1993; 13: 296–301.

Yatzidis H. A new stable bicarbonate dialysis solution for peritoneal dialysis: preliminary report. Perit Dial Int 1991; 11: 224–7.

Yatzidis H. A new single bicarbonate CAPD solution. In: La Greca G. , Ronco C. , Feriani M. , Chiaramonte S. , Conz P. , eds. Peritoneal Dialysis. Milan: Wichtig, 1991: 151–7.

Feriani M. , Passlick-Deetjen J. , La Greca G. Factors affecting bicarbonate transfer with bicarbonate-containing CAPD solution. Perit Dial Int 1995; 15: 336–41.

Passlick-Deetjen J. , Kirchgessner J. Bicarbonate: the alternative buffer for peritoneal dialysis. Perit Dial Int 1996; 16(Suppl 1): S109–13.

Struijk D.G. , Krediet R.T. , Imholz A.L.T. , Koomen G.C.M. , Arisz L. Fluid kinetics in CAPD patients during dialysis with a bicarbonate-based hypoosmolar solution. Blood Purif 1996; 14: 217–26.

Rubin J. , Nolph K.D. , Joshua I.G. , Miller F.N. , Wiegman D.L. , Harris P.D. Clinical studies with nonvasoactive peritoneal dialysis solution. J Lab Clin Med 1979; 93: 910–5.

Miller F.N. , Nolph K.D. , Sorkin M.I. , Gloor H.J. The influence of solute composition on protein loss during peritoneal dialysis. Kidney Int 1983; 23: 35–9.

Slingeneyer A. , Pryzbylski C. , Rolland R. , Mion C. A new bicarbonate buffered solution for CAPD. Perit Dial Int 1993; 13(Suppl 1): S57.

Yatzidis H. Enhanced ultrafiltration in rabbits with bicarbonate glycylglycine peritoneal dialysis solution. Perit Dial Int 1993; 13: 302–6.

Krediet R.T. , Boeschoten E.W. , Zuyderhoudt F.M.J. , Arisz L. The relationship between peritoneal glucose absorption and body fluid loss by ultrafiltration during continuous ambulatory peritoneal dialysis. Clin Nephrol 1987; 27: 51–5.

Wieslander A. , Linden T. Glucose degradation and cytotoxicity in PD fluids. Perit Dial Int 1996; 16(Suppl 1): S114–8.

Lamb E. , Catell V.R. , Dawnay A. Glycated albumin in serum and dialysate of patients on continuous ambulatory peritoneal dialysis. Clin Sci 1993; 84: 619–26.

Yamada K. , Miyakasa Y. , Hamaguchi K. Immunohistochemical study of human advanced glycosylation end products (AGE) in chronic renal failure. Clin Nephrol 1994; 42: 354–61.

Graf H. , Stumvoll H.K. , Luger A. , Prager R. Effect of amino acid infusion on glomerular filtration rate. N Engl J Med 1983; 308: 159–60.

Ter Wee P.M. , Geerlings W. , Rosman J.B. , Sluiter W.J. , van der Geest S. , Donker A.J.M. Testingrenal reserve filtration capacity with an amino acid solution. Nephron 1985; 41: 193–9.

Williams P.F. , Marliss E.B. , Anderson Amino acid absorption following intraperitoneal administration in CAPD patients. Perit Dial Bull 1982; 2: 124–30.

Goodship T.H.J. , Lloyd S. , McKenzie P.W. Short-term studies on the use of amino acids as an osmotic agent in continuous ambulatory peritoneal dialysis. Clin Sci 1987; 73: 471–8.

Bruno M. , Bagnis C. , Marangella M. , Rovera L. , Cantaluppi A. , Linari F. CAPD with an amino acid dialysis solution: a long-term cross-over study. Kidney Int 1989; 35: 1189–94.

Lindholm B. , Werynski A. , Bergström J. Peritoneal dialysis with amino acid solutions: fluid and solute transport kinetics. Artif Org 1988; 12: 2–10.

Waniewski J. , Werynski A. , Heimbürger O. , Park M.S. , Lindholm B. Effect of alternative osmotic agents on peritoneal transport. Blood Purif 1993; 11: 248–64.

Steinhauer H.B. , Lubrick-Birkner I. , Kluthe R. , Horl W.H. , Schollmeyer P. Amino acid dialysate stimulates peritoneal prostaglandin E₂ generation in humans. Adv Perit Dial 1988; 4: 21–6.

Steinhauer H.B. , Lubrick-Birkner I. , Kluthe R. , Baumann G. , Schollmeyer P. Effect of amino acid based dialysis solution on peritoneal permeability and prostanoid generation in patients undergoing continuous ambulatory peritoneal dialysis. Am J Nephrol 1992; 12: 61–7.

Zemel D. , Koomen G.C.M. , Hart A.A.M. , ten Berge R.J.M. , Struijk D.G. , Krediet R.T. Relationship of TNFα, interleukin-6 and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med 1993; 122: 686–96.

Zemel D. , Struijk D.G. , Dinkla C. , Stolk L.M. , ten Berge R.J.M. , Krediet R.T. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med 1995; 126: 204–15.

Young G. , Dibble J.B. , Taylor A.E. , Kendall S. , Brownjohn A.M. A longitudinal study on the effects of amino acid-based CAPD fluid on amino acid retention and protein loss. Nephrol Dial Transplant 1989; 4: 900–5.

Douma C.E. , de Waart DR , Struijk D.G. , Krediet R.T. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide? Clin Nephrol 1996; 45: 295–302.

Nolph K.D. , Popovich R.P. , Ghods A.J. , Twardowksi Z.J. Determinants of low clearances of small solutes during peritoneal dialysis. Kidney Int 1978; 13: 117–23.

Grzegorzewska A.E. , Antoniewicz K. An indirect estimation of effective peritoneal capillary blood flow in peritoneally dialyzed uremic patients. Perit Dial Int 1993; 13(Suppl 2): S39–40.

de Paepe M. , Matthys E. , Peluso F. , Dolkart R. , Lameire N. Experience with glycerol as the osmotic agent in peritoneal dialysis in diabetic and non-diabetic patients. In: Keen H. , Legrain M. , eds. Prevention and treatment of diabetic nephropathy. Boston, MTPPress 1983: 299–13.

Matthys E. , Dolkart R. , Lameire N. Extended use of a glycerol-containing dialysate in diabetic CAPD patients. Pent Dial Bull 1987; 7: 10–5.

Daniels F.H. , Leonard E.F. , Cortell S. Glucose and glycerol compared as osmotic agents for peritoneal dialysis. Kidney Int 1984; 25: 20–5.

Matthys E. , Dolkart R. , Lameire N. Potential hazards of glycerol dialysate in diabetic CAPD patients. Perit Dial Bull 1987; 7: 16–9.

Heaton A. , Ward M.K. , Johnston D.G. , Nicholson D.V. , Alberti KGMM , Kerr D.N.S. Short-term studies on the use of glycerol as an osmotic agent in continuous ambulatory peritoneal dialysis (CAPD). Clin Sci 1984; 67: 121–30.

Lindholm B. , Werynski A. , Bergstrom J. Kinetics of peritoneal dialysis with glycerol and glucose as osmotic agents. ASAIO Trans 1987; 33: 19–27.

Klein E. , Ward R.A. , Williams T.E. , Feldhoff P.W. Peptides as substitute osmotic agents for glucose in peritoneal dialysate. ASAIO Trans 1986; 32: 550–3.

Martis L. , Burke R. , Klein E. Evaluation of a peptide-based solution for peritoneal dialysis. Perit Dial Int 1993; 13(Suppl 2): S92–4.

Imholz A.L.T. , Lameire N. , Faict D. Evaluation of short-chain polypeptides as an osmotic agent in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1994; 14: 215–22.

Krediet R.T. , Imholz A.L.T. , Lameire N. , Faict D. , Koomen G.C.M. , Martis L. The use of peptides in peritoneal dialysis fluids. Perit Dial Int 1994; 14(Suppl 3): S152–7.

Krediet R.T. , Struijk D.G. , Koomen G.C.M. , Hoek F.J. , Arisz L. The disappearance of macromolecules from the peritoneal cavity during continuous ambulatory peritoneal dialysis (CAPD) is not dependent on molecular size. Perit Dial Int 1990; 10: 147–152.

Mistry C.D. , Gokal R. Can ultrafiltration occur with a hypo-osmolar solution in peritoneal dialysis?: the role for “colloid” osmosis. Clin Sci 1993; 85: 495–500.

Mistry C.D. , Mallick N.P. , Gokal R. Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchanges. Lancet 1987; 2: 178–82.

Mistry C.D. , Gokal R. , Peers E.M. , and the MIDAS study group. A randomized multicenter clinical trial comparing isosmolar Icodextrin with hyperosmolar glucose solutions in CAPD. Kidney Int 1994; 46: 496–503.

Mistry C.D. , O'Donoghue D.J. , Nelson S. , Gokal R. , Ballardie F.W. Kinetic and clinical studies of β_2-microglobulin in continuous ambulatory peritoneal dialysis: influence of renal and enhanced peritoneal clearances using glucose polymer. Nephrol Dial Transplant 1990; 5: 13–9.

Imholz A.L.T. , Brown C.B. , Koomen G.C.M. , Arisz L. , Krediet R.T. The effect of glucose polymers on water removal and protein clearances during CAPD. Adv Perit Dial 1993; 9: 25–30.

Krediet R.T. , Brown C.B. , Imholz A.L.T. , Koomen G.C.M. Protein clearance and icodextrin. Perit Dial Int 1994; 14(Suppl 2): S39–44.

Heimburger O. , Waniewski J. , Werynski A. , Tranaeus A. , Lindholm B. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 1990; 38: 495–506.

Krediet R.T. , Imholz A.L.T. , Struijk D.G. , Koomen G.C.M. , Arisz L. Ultrafiltration failure in continuous ambulatory peritoneal dialysis. PeritDial Int 1993; 13(Suppl 2): S59–66.

Stein A. , Peers E. , Hattersley J. , Harris K. , Feehally J. , Walls J. , and the MIDAS study group. Clinical experience with icodextrin in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1994; 14(Suppl 2): S51–4.

Gokal R. , Mistry C.D. , Peers E.M. , and the MIDAS study group. Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD. Perit Dial Int 1995; 15: 226–30.